<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font5" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font6" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font7" size="9" family="GillSans,BoldItalic" color="#000000"/>
<text top="41" left="55" width="88" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">CytoJournal 2007, 4 :7<i>CytoJournal</i></text>
<text top="41" left="392" width="162" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.cytojournal.com/content/4/1/7</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t3" reading_order_no="103" segment_no="17" tag_type="text">Page 2 of 10<b>4</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="104" segment_no="18" tag_type="text">(page number not for citation purposes)</text>
<text top="87" left="55" width="60" height="10" font="font4" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Background</text>
<text top="98" left="55" width="241" height="9" font="font5" id="p1_t6" reading_order_no="3" segment_no="4" tag_type="text">Cervical smears may exhibit unequivocal 'low grade squa-</text>
<text top="110" left="55" width="241" height="9" font="font5" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="text">mous intraepithelial lesion' (LSIL) in association with<i>(page number not for citation purposes)</i></text>
<text top="122" left="55" width="241" height="9" font="font5" id="p1_t8" reading_order_no="5" segment_no="4" tag_type="text">atypical cells cytomorphologically suspicious for, but not<b>Background</b></text>
<text top="134" left="55" width="241" height="9" font="font5" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="text">sufficient to be interpreted as, 'high grade squamous</text>
<text top="145" left="55" width="241" height="9" font="font5" id="p1_t10" reading_order_no="7" segment_no="4" tag_type="text">intraepithelial lesion' (HSIL) [1,2]. This concurrence has</text>
<text top="157" left="55" width="241" height="9" font="font5" id="p1_t11" reading_order_no="8" segment_no="4" tag_type="text">been identified recently by many laboratories, but its</text>
<text top="169" left="55" width="241" height="9" font="font5" id="p1_t12" reading_order_no="9" segment_no="4" tag_type="text">reporting is not addressed in the 2001 Bethesda System</text>
<text top="181" left="55" width="241" height="9" font="font5" id="p1_t13" reading_order_no="10" segment_no="4" tag_type="text">terminology (Bethesda 2001) [3-5]. Lack of a standard-<a href="">L) [1,2]. Th</a>is concurrence has</text>
<text top="192" left="55" width="241" height="9" font="font5" id="p1_t14" reading_order_no="11" segment_no="4" tag_type="text">ized method of reporting, however, may affect proper</text>
<text top="204" left="55" width="241" height="9" font="font5" id="p1_t15" reading_order_no="12" segment_no="4" tag_type="text">application of American Society for Colposcopy and Cer-</text>
<text top="216" left="55" width="241" height="9" font="font5" id="p1_t16" reading_order_no="13" segment_no="4" tag_type="text">vical Pathology (ASCCP) guidelines based on Bethesda<a href="">[3</a>-<a href="">5]</a>. Lack of a standard-</text>
<text top="228" left="55" width="241" height="9" font="font5" id="p1_t17" reading_order_no="14" segment_no="4" tag_type="text">2001 [6,7]. Although 'atypical squamous cells, cannot</text>
<text top="239" left="55" width="241" height="9" font="font5" id="p1_t18" reading_order_no="15" segment_no="4" tag_type="text">exclude HSIL' (ASC-H) is not a definitive interpretation, it</text>
<text top="251" left="55" width="241" height="9" font="font5" id="p1_t19" reading_order_no="16" segment_no="4" tag_type="text">is related to an increased risk of higher-grade lesions on</text>
<text top="263" left="55" width="241" height="9" font="font5" id="p1_t20" reading_order_no="17" segment_no="4" tag_type="text">biopsy [3]. On the contrary, LSIL is a definitive interpreta-<a href="">001 [6,7</a>]. Although 'atypical squamous cells, cannot</text>
<text top="275" left="55" width="241" height="9" font="font5" id="p1_t21" reading_order_no="18" segment_no="4" tag_type="text">tion with relatively lower prevalence of high-grade lesion</text>
<text top="286" left="55" width="95" height="9" font="font5" id="p1_t22" reading_order_no="19" segment_no="4" tag_type="text">on subsequent biopsy.</text>
<text top="310" left="55" width="241" height="9" font="font5" id="p1_t23" reading_order_no="20" segment_no="8" tag_type="text">Currently, the reporting pattern to communicate this con-<a href="">3</a>]. On the contrary, LSIL is a definitive interpreta-</text>
<text top="322" left="55" width="241" height="9" font="font5" id="p1_t24" reading_order_no="21" segment_no="8" tag_type="text">currence varies amongst different cytopathology laborato-</text>
<text top="333" left="55" width="241" height="9" font="font5" id="p1_t25" reading_order_no="22" segment_no="8" tag_type="text">ries. In our institution, for statistical and quality assurance</text>
<text top="345" left="55" width="241" height="9" font="font5" id="p1_t26" reading_order_no="23" segment_no="8" tag_type="text">reasons, we report this concurrence under definitive inter-</text>
<text top="357" left="55" width="241" height="9" font="font5" id="p1_t27" reading_order_no="24" segment_no="8" tag_type="text">pretation as LSIL with a comment that ASC-H cells are</text>
<text top="369" left="55" width="241" height="9" font="font5" id="p1_t28" reading_order_no="25" segment_no="8" tag_type="text">also present. Others essentially follow a reverse approach</text>
<text top="380" left="55" width="241" height="9" font="font5" id="p1_t29" reading_order_no="26" segment_no="8" tag_type="text">and report it as ASC-H with LSIL in the comment. Some</text>
<text top="392" left="55" width="241" height="9" font="font5" id="p1_t30" reading_order_no="27" segment_no="8" tag_type="text">interpreters may choose to combine the associated ASC-H</text>
<text top="404" left="55" width="241" height="9" font="font5" id="p1_t31" reading_order_no="28" segment_no="8" tag_type="text">component with LSIL and report the combination as</text>
<text top="416" left="55" width="241" height="9" font="font5" id="p1_t32" reading_order_no="29" segment_no="8" tag_type="text">HSIL, which may lead to a potentially high false positivity</text>
<text top="427" left="55" width="241" height="9" font="font5" id="p1_t33" reading_order_no="30" segment_no="8" tag_type="text">rate. Rarely, the ASC-H component may be downgraded</text>
<text top="439" left="55" width="241" height="9" font="font5" id="p1_t34" reading_order_no="31" segment_no="8" tag_type="text">to 'atypical squamous cells of undetermined significance'</text>
<text top="451" left="55" width="241" height="9" font="font5" id="p1_t35" reading_order_no="32" segment_no="8" tag_type="text">(ASCUS) with the final interpretation as LSIL, with poten-</text>
<text top="463" left="55" width="206" height="9" font="font5" id="p1_t36" reading_order_no="33" segment_no="8" tag_type="text">tially false negative results for high-grade lesions.</text>
<text top="486" left="55" width="241" height="9" font="font5" id="p1_t37" reading_order_no="34" segment_no="11" tag_type="text">In the current study, we evaluated cervical biopsies in</text>
<text top="498" left="55" width="241" height="9" font="font5" id="p1_t38" reading_order_no="35" segment_no="11" tag_type="text">cases of "LSIL with ASC-H" (LSIL-H) (Figure 2 &amp;3) in</text>
<text top="510" left="55" width="241" height="9" font="font5" id="p1_t39" reading_order_no="36" segment_no="11" tag_type="text">comparison to other categories in Bethesda 2001, to see if</text>
<text top="521" left="55" width="205" height="9" font="font5" id="p1_t40" reading_order_no="37" segment_no="11" tag_type="text">this designation as a distinct category is justified.</text>
<text top="545" left="55" width="50" height="8" font="font6" id="p1_t41" reading_order_no="38" segment_no="12" tag_type="text">pv dna testing<a href="">2 &amp;3) in</a></text>
<text top="555" left="55" width="96" height="9" font="font7" id="p1_t42" reading_order_no="39" segment_no="13" tag_type="title">Materials and methods</text>
<text top="567" left="55" width="241" height="9" font="font5" id="p1_t43" reading_order_no="40" segment_no="14" tag_type="text">We studied SurePath™ [TriPath Imaging Inc, Burlington,</text>
<text top="579" left="55" width="241" height="9" font="font5" id="p1_t44" reading_order_no="41" segment_no="14" tag_type="text">NC] preparations of cervical specimens over a one year</text>
<text top="590" left="55" width="241" height="9" font="font5" id="p1_t45" reading_order_no="42" segment_no="14" tag_type="text">period (Figure 1). Initial cytopathologic interpretations<i><b>Materials and methods</b></i></text>
<text top="602" left="55" width="241" height="9" font="font5" id="p1_t46" reading_order_no="43" segment_no="14" tag_type="text">were performed by more than five different cytopatholo-</text>
<text top="614" left="55" width="241" height="9" font="font5" id="p1_t47" reading_order_no="44" segment_no="14" tag_type="text">gists, based on Bethesda 2001 criteria and were represent-</text>
<text top="626" left="55" width="197" height="9" font="font5" id="p1_t48" reading_order_no="45" segment_no="14" tag_type="text">ative of general cytology reporting patterns [4].<a href="">riod (Figure 1). Initial cytopath</a>ologic interpretations</text>
<text top="649" left="55" width="241" height="9" font="font5" id="p1_t49" reading_order_no="46" segment_no="15" tag_type="text">LSIL-H was defined as cases with unequivocal LSIL, in</text>
<text top="661" left="55" width="241" height="9" font="font5" id="p1_t50" reading_order_no="47" segment_no="15" tag_type="text">concurrence with ASC-H (Figure 2 and 3). ASC-H cells</text>
<text top="673" left="55" width="241" height="9" font="font5" id="p1_t51" reading_order_no="48" segment_no="15" tag_type="text">showed cytomorphologic features reported previously [8].<a href="">4</a>].</text>
<text top="684" left="55" width="241" height="9" font="font5" id="p1_t52" reading_order_no="49" segment_no="15" tag_type="text">As observed in a subset of ASC-H, some of these cases</text>
<text top="696" left="55" width="241" height="9" font="font5" id="p1_t53" reading_order_no="50" segment_no="15" tag_type="text">showed small atypical parakeratotic (SAPK) cells (Figure<a href="">2</a> and<a href=""> 3). </a>ASC-H cells</text>
<text top="708" left="55" width="241" height="9" font="font5" id="p1_t54" reading_order_no="51" segment_no="15" tag_type="text">3), which may demonstrate superficial resemblance to<a href="">8</a>].</text>
<text top="720" left="55" width="200" height="9" font="font5" id="p1_t55" reading_order_no="52" segment_no="15" tag_type="text">high grade cells in liquid based cytology [9,10].</text>
<text top="87" left="313" width="241" height="9" font="font5" id="p1_t56" reading_order_no="53" segment_no="3" tag_type="text">The cytology results were correlated with concurrent biop-</text>
<text top="98" left="313" width="241" height="9" font="font5" id="p1_t57" reading_order_no="54" segment_no="3" tag_type="text">sies (both colposcopically-guided and LEEP biopsies) per-<a href="">3), which m</a>ay demonstrate superficial resemblance to</text>
<text top="110" left="313" width="241" height="9" font="font5" id="p1_t58" reading_order_no="55" segment_no="3" tag_type="text">formed at the time of, or within 3 months of cytologic<a href="">9,10]</a>.</text>
<text top="122" left="313" width="241" height="9" font="font5" id="p1_t59" reading_order_no="56" segment_no="3" tag_type="text">interpretation. Many institutions, in addition to our pri-</text>
<text top="134" left="313" width="241" height="9" font="font5" id="p1_t60" reading_order_no="57" segment_no="3" tag_type="text">mary hospital, submitted cervical cytology specimens.</text>
<text top="145" left="313" width="241" height="9" font="font5" id="p1_t61" reading_order_no="58" segment_no="3" tag_type="text">Cervical biopsies from some outside institutions were not</text>
<text top="157" left="313" width="241" height="9" font="font5" id="p1_t62" reading_order_no="59" segment_no="3" tag_type="text">sent to our institution for surgical pathology and the cyto-</text>
<text top="169" left="313" width="241" height="9" font="font5" id="p1_t63" reading_order_no="60" segment_no="3" tag_type="text">histo correlation was available in only a fraction of cases.</text>
<text top="181" left="313" width="241" height="9" font="font5" id="p1_t64" reading_order_no="61" segment_no="3" tag_type="text">The cervical biopsy results for cases with cytologic inter-</text>
<text top="192" left="313" width="241" height="9" font="font5" id="p1_t65" reading_order_no="62" segment_no="3" tag_type="text">pretation as LSIL, LSIL-H, and ASC-H were compared</text>
<text top="204" left="313" width="198" height="9" font="font5" id="p1_t66" reading_order_no="63" segment_no="3" tag_type="text">using the Chi-square test for statistical analysis.</text>
<text top="228" left="313" width="241" height="9" font="font5" id="p1_t67" reading_order_no="64" segment_no="5" tag_type="text">In addition, the status of HPV DNA testing (Hybrid Cap-</text>
<text top="239" left="313" width="241" height="9" font="font5" id="p1_t68" reading_order_no="65" segment_no="5" tag_type="text">ture (HC) II, Digene, Silver Spring, MD, USA) performed</text>
<text top="251" left="313" width="241" height="9" font="font5" id="p1_t69" reading_order_no="66" segment_no="5" tag_type="text">within a year of biopsy was noted in LSIL-H cases with</text>
<text top="263" left="313" width="60" height="9" font="font5" id="p1_t70" reading_order_no="67" segment_no="5" tag_type="text">biopsy results.</text>
<text top="287" left="313" width="36" height="10" font="font4" id="p1_t71" reading_order_no="68" segment_no="6" tag_type="title">Results</text>
<text top="298" left="313" width="241" height="9" font="font5" id="p1_t72" reading_order_no="69" segment_no="7" tag_type="text">We studied 77,979 cases over a one year period (Figure 1).</text>
<text top="310" left="313" width="241" height="9" font="font5" id="p1_t73" reading_order_no="70" segment_no="7" tag_type="text">Out of these 1,970 cases (ages 16 to 65 years) were inter-</text>
<text top="322" left="313" width="241" height="9" font="font5" id="p1_t74" reading_order_no="71" segment_no="7" tag_type="text">preted as abnormal (1,523 LSIL, 146 LSIL-H (Figure 2<b>Results</b></text>
<text top="333" left="313" width="241" height="9" font="font5" id="p1_t75" reading_order_no="72" segment_no="7" tag_type="text">&amp;3), 109 ASC-H, and 192 HSIL). The cyto-histo correla-<a href=""> (Figure 1).</a></text>
<text top="345" left="313" width="241" height="9" font="font5" id="p1_t76" reading_order_no="73" segment_no="7" tag_type="text">tion was available in 40% (792 of 1,970) cases. These</text>
<text top="357" left="313" width="241" height="9" font="font5" id="p1_t77" reading_order_no="74" segment_no="7" tag_type="text">included 557 LSIL, 88 LSIL-H, 38 ASC-H, and 109 HSIL<a href="">2</a></text>
<text top="369" left="313" width="44" height="9" font="font5" id="p1_t78" reading_order_no="75" segment_no="7" tag_type="text">(Figure 1).<a href="">&amp;3</a>), 109 ASC-H, and 192 HSIL). The cyto-histo correla-</text>
<text top="392" left="313" width="241" height="9" font="font5" id="p1_t79" reading_order_no="76" segment_no="9" tag_type="text">The biopsy results were grouped into: A. negative for dys-</text>
<text top="404" left="313" width="241" height="9" font="font5" id="p1_t80" reading_order_no="77" segment_no="9" tag_type="text">plasia (ND), B. low grade (HPV, CIN1, or CIN1 with</text>
<text top="416" left="313" width="241" height="9" font="font5" id="p1_t81" reading_order_no="78" segment_no="9" tag_type="text">HPV), and C. high grade (CIN 2 and above) (Table 1).<a href="">(Figure 1).</a></text>
<text top="427" left="313" width="241" height="9" font="font5" id="p1_t82" reading_order_no="79" segment_no="9" tag_type="text">Positive predictive value (PPV) for each category of biopsy</text>
<text top="439" left="313" width="241" height="9" font="font5" id="p1_t83" reading_order_no="80" segment_no="9" tag_type="text">result was calculated for LSIL, LSIL-H, ASC-H, and HSIL</text>
<text top="451" left="313" width="106" height="9" font="font5" id="p1_t84" reading_order_no="81" segment_no="9" tag_type="text">interpretations (Table 1).<a href=""> (Table 1).</a></text>
<text top="474" left="313" width="241" height="9" font="font5" id="p1_t85" reading_order_no="82" segment_no="10" tag_type="text">LSIL-H (Figure 2 &amp;3) had a lower prevalence of negative</text>
<text top="486" left="313" width="241" height="9" font="font5" id="p1_t86" reading_order_no="83" segment_no="10" tag_type="text">biopsy results, compared to ASC-H and LSIL (24% nega-</text>
<text top="498" left="313" width="241" height="9" font="font5" id="p1_t87" reading_order_no="84" segment_no="10" tag_type="text">tive results with LSIL-H versus 32% with ASC-H and 32%<a href=""> (Table 1</a>).</text>
<text top="510" left="313" width="241" height="9" font="font5" id="p1_t88" reading_order_no="85" segment_no="10" tag_type="text">with LSIL) (Table 1). LSIL-H had a higher chance of asso-<a href="">ure 2 &amp;3</a>) had a lower prevalence of negative</text>
<text top="521" left="313" width="241" height="9" font="font5" id="p1_t89" reading_order_no="86" segment_no="10" tag_type="text">ciation with high grade dysplasia on biopsy, comparable</text>
<text top="533" left="313" width="241" height="9" font="font5" id="p1_t90" reading_order_no="87" segment_no="10" tag_type="text">to that for ASC-H (Positive predictive value [PPV] of 33%</text>
<text top="545" left="313" width="241" height="9" font="font5" id="p1_t91" reading_order_no="88" segment_no="10" tag_type="text">with LSIL-H and 31% with ASC-H). LSIL alone was asso-<a href="">IL) (Table 1</a>). LSIL-H had a higher chance of asso-</text>
<text top="557" left="313" width="241" height="9" font="font5" id="p1_t92" reading_order_no="89" segment_no="10" tag_type="text">ciated with a significantly lower risk (PPV 10%) for high</text>
<text top="568" left="313" width="241" height="9" font="font5" id="p1_t93" reading_order_no="90" segment_no="10" tag_type="text">grade dysplasia as compared to LSIL-H (PPV 33%). PPV of</text>
<text top="580" left="313" width="241" height="9" font="font5" id="p1_t94" reading_order_no="91" segment_no="10" tag_type="text">LSIL-H (33%) was lower for high grade lesions as com-</text>
<text top="592" left="313" width="241" height="9" font="font5" id="p1_t95" reading_order_no="92" segment_no="10" tag_type="text">pared to HSIL (69%). LSIL-H was associated with higher</text>
<text top="604" left="313" width="241" height="9" font="font5" id="p1_t96" reading_order_no="93" segment_no="10" tag_type="text">number of negative biopsy results (24%) as compared to</text>
<text top="615" left="313" width="241" height="9" font="font5" id="p1_t97" reading_order_no="94" segment_no="10" tag_type="text">HSIL (5%). However, as compared to ASC-H (32%), the</text>
<text top="627" left="313" width="241" height="9" font="font5" id="p1_t98" reading_order_no="95" segment_no="10" tag_type="text">prevalence of negative biopsy results with LSIL-H was rel-</text>
<text top="639" left="313" width="166" height="9" font="font5" id="p1_t99" reading_order_no="96" segment_no="10" tag_type="text">atively lower (24%) (Table 1, Figure 4).</text>
<text top="662" left="313" width="241" height="9" font="font5" id="p1_t100" reading_order_no="97" segment_no="16" tag_type="text">PPVs between different groups were compared by per-</text>
<text top="674" left="313" width="241" height="9" font="font5" id="p1_t101" reading_order_no="98" segment_no="16" tag_type="text">forming two separate 2 × 3 Chi-square tests for LSIL versus</text>
<text top="686" left="313" width="241" height="9" font="font5" id="p1_t102" reading_order_no="99" segment_no="16" tag_type="text">LSIL-H and LSIL-H versus ASC-H (Table 1). Applying the<a href="">) (Table 1, Figure 4)</a>.</text>
<text top="698" left="313" width="241" height="9" font="font5" id="p1_t103" reading_order_no="100" segment_no="16" tag_type="text">Bonferroni correction for multiple testing, the significance</text>
<text top="709" left="313" width="241" height="9" font="font5" id="p1_t104" reading_order_no="101" segment_no="16" tag_type="text">level was adjusted to 0.025. The differences between LSIL</text>
<text top="721" left="313" width="241" height="9" font="font5" id="p1_t105" reading_order_no="102" segment_no="16" tag_type="text">and LSIL-H were statistically significant (Chi-square value<a href="">1). Appl</a>ying the</text>
</page>
</pdf2xml>
